Phenotype
|
Fish
|
Conditions
|
Figures
|
blood vessel nr2f1b expression increased distribution, abnormal
|
TL + MO4-rbpja,rbpjb
|
control
|
Fig. 6
from Li et al., 2015
|
whole organism nr2f1b expression increased distribution, abnormal
|
TL + MO4-rbpja,rbpjb
|
control
|
Fig. 6
from Li et al., 2015
|
pronephric tubule morphology, abnormal
|
TU + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
interrenal primordium increased size, abnormal
|
TU + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
pronephric podocyte decreased amount, abnormal
|
TU + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
central nervous system cellular quality, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 5
from Yeo et al., 2007
|
angiogenic sprout increased amount, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
nucleate erythrocyte mislocalised, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S2
from Siekmann et al., 2007
|
fin regeneration decreased process quality, abnormal
|
WT + MO4-rbpja,rbpjb
|
physical alteration: anatomical structure
|
Fig. 3
from Münch et al., 2013
|
ventricular system distended, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S2
from Siekmann et al., 2007
|
posterior lateral line ganglion neuron increased amount, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 1
from Mizoguchi et al., 2011
|
ventricular system increased accumulation nucleate erythrocyte, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S2
from Siekmann et al., 2007
|
hindbrain epithelium disorganized, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Qiu et al., 2009
|
cranial vasculature broken, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S2
from Siekmann et al., 2007
|
intersegmental vessel structure, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
rhombomere boundary formation disrupted, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Qiu et al., 2009
|
blood vessel endothelial cell proliferation involved in sprouting angiogenesis process quality, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
hindbrain development disrupted, abnormal
|
WT + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Qiu et al., 2009
|
pronephric podocyte decreased amount, abnormal
|
TU + MO1-foxc1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
pronephric tubule morphology, abnormal
|
TU + MO1-foxc1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
interrenal primordium increased size, abnormal
|
TU + MO1-foxc1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
pronephric tubule absent, abnormal
|
TU + MO3-wt1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
interrenal primordium increased size, abnormal
|
TU + MO3-wt1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
pronephric podocyte decreased amount, abnormal
|
TU + MO3-wt1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 3
from O'Brien et al., 2011
|
whole organism lacks all parts of type dorsal aorta, abnormal
|
WT + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 4 ,
Fig. 5
from Sacilotto et al., 2013
|
axial blood vessel decreased amount, abnormal
|
WT + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 5
from Sacilotto et al., 2013
|
artery development arrested, abnormal
|
WT + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 4 ,
Fig. 5 ,
Fig. S8
from Sacilotto et al., 2013
|
pronephros lacks all parts of type pronephric podocyte, abnormal
|
hnf1bahi1843Tg/hi1843Tg + MO1-hnf1bb + MO3-wt1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Naylor et al., 2013
|
podocyte differentiation decreased occurrence, abnormal
|
hnf1bahi1843Tg/hi1843Tg + MO1-hnf1bb + MO3-wt1a + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Naylor et al., 2013
|
peripheral neuron decreased length, abnormal
|
knu2Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from So et al., 2009
|
blood vessel endothelial cell proliferation involved in sprouting angiogenesis process quality, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
trunk vasculature EGFP expression decreased amount, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
control
|
Fig. 3
from Overman et al., 2017
|
angiogenic sprout increased amount, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
intersegmental vessel structure, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
trunk vasculature EGFP expression decreased amount, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
chemical treatment by environment: pharmaceutical
|
Fig. 3
from Overman et al., 2017
|
whole organism EGFP expression decreased amount, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb
|
chemical treatment by environment: pharmaceutical
|
Fig. 3
from Overman et al., 2017
|
intersegmental vessel increased branchiness, abnormal
|
s843Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 7
from Zhou et al., 2015
|
intersegmental vessel angiogenesis increased process quality, abnormal
|
s843Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 7
from Zhou et al., 2015
|
blood circulation disrupted, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S1
from Siekmann et al., 2007
|
intersegmental vessel structure, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 1
from Siekmann et al., 2007
|
intersegmental vessel increased mass density, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Jensen et al., 2012
|
blood vessel development disrupted, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 5
from Sacilotto et al., 2013
|
intersegmental vessel disorganized, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Jensen et al., 2012
|
intersegmental vessel has extra parts of type blood vessel, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Jensen et al., 2012
|
intersegmental vessel mislocalised, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 1
from Siekmann et al., 2007
|
intersegmental vessel has extra parts of type vascular sprouts, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 4
from Jensen et al., 2012
|
intersegmental artery structure, abnormal
|
y1Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. S1
from Siekmann et al., 2007
|
intersegmental vessel structure, abnormal
|
y7Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Siekmann et al., 2007
|
blood vessel endothelial cell increased amount, abnormal
|
y7Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Siekmann et al., 2007
|
cell migration involved in sprouting angiogenesis process quality, abnormal
|
y7Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Siekmann et al., 2007
|
blood vessel endothelial cell proliferation involved in sprouting angiogenesis process quality, abnormal
|
y7Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 2
from Siekmann et al., 2007
|
intersegmental artery blood vessel endothelial cell increased amount, abnormal
|
y7Tg + MO4-rbpja,rbpjb
|
control
|
Fig. 5
from Lamont et al., 2016
Fig. 3,
Fig. S5
from Siekmann et al., 2007
|
dorsal longitudinal anastomotic vessel blood vessel development occurrence, ameliorated
|
s843Tg + MO2-uxt + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 7
from Zhou et al., 2015
|
intersegmental vessel angiogenesis process quality, ameliorated
|
s843Tg + MO2-uxt + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 7
from Zhou et al., 2015
|
intersegmental artery blood vessel endothelial cell amount, ameliorated
|
y7Tg + MO4-isl2a + MO4-rbpja,rbpjb + MO5-isl2a
|
control
|
Fig. 5
from Lamont et al., 2016
|
artery development arrested, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
whole organism lacks all parts of type dorsal aorta, abnormal
|
lcr1Tg + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 4
from Sacilotto et al., 2013
|
artery development arrested, abnormal
|
y1Tg + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 5
from Sacilotto et al., 2013
|
axial blood vessel decreased amount, abnormal
|
y1Tg + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. 5
from Sacilotto et al., 2013
|
intersegmental vessel cell increased amount, abnormal
|
ci5Tg; y7Tg + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 6
from Li et al., 2015
|
intersegmental vessel cell amount, ameliorated
|
ci5Tg; y7Tg + MO4-nr2f1b + MO4-rbpja,rbpjb
|
standard conditions
|
Fig. 6
from Li et al., 2015
|
ventral wall of dorsal aorta endothelial cell EGFP expression absent, abnormal
|
gfi1aaqmc551Gt/+; sd2Tg + MO4-rbpja,rbpjb
|
control
|
Fig. 4
from Thambyrajah et al., 2016
|
hematopoietic multipotent progenitor cell EGFP expression absent, abnormal
|
gfi1aaqmc551Gt/+; sd2Tg + MO4-rbpja,rbpjb
|
control
|
Fig. 4
from Thambyrajah et al., 2016
|
ventral wall of dorsal aorta hematopoietic cell EGFP expression absent, abnormal
|
gfi1aaqmc551Gt/+; sd2Tg + MO4-rbpja,rbpjb
|
control
|
Fig. 4
from Thambyrajah et al., 2016
|
blood circulation arrested, abnormal
|
s843Tg; sd2Tg + MO4-rbpja,rbpjb + MO5-sox18 + MO5-sox7
|
standard conditions
|
Fig. S7
from Sacilotto et al., 2013
|